NTLA Intellia Therapeutics
- 20.860
- +0.840+4.20%
Intellia Therapeutics News
Intellia Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dube Michael P
Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sepp-Lorenzino Laura
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BASTA JAMES
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hicks Derek
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clark Eliana
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Goddard Glenn
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lebwohl David
Intellia Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONARD JOHN M
Intellia Therapeutics | 424B5: Prospectus
Intellia Therapeutics | 424B5: Prospectus
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Intellia Therapeutics | 10-K: Annual report
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.32%)
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARK Investment Management LLC(12.74%)
Analysis
Price Target
No Data
